Abstract
Bronchiectasis occurs de novo in haematological malignancy and is associated with significant mortality and morbidity. Rituximab predisposes to IgG deficiency and survival time is significantly associated with age, FEV(1) % and stem cell transplantation. http://bit.ly/2KZwCZt.